Pulmonary Hypertension Association home
Pulmonary Hypertension Association
 contact us | join PHA | site map/search

Spring 2003, Vol. 2, No. 1

Editor’s Memo
 

Inside the Surgical Suite: Meeting the Challenges of CTEPH

It is so rare to find a curable cause of pul-monary arterial hypertension (PAH). In preparing the topics to be covered for this issue we decided that surgically curable PAH is one of
the most challenging situations we face, particularly
in terms of appropriate selection of patients and in our preoperative preparation. One of the major challenges confronting us is bringing the right patient into the operating room suite and addressing all of the issues impinging on our decision to perform surgery as we determine whether the chronic thromboembolic pulmonary hypertension (CTEPH) is surgically accessible and to what extent we can make a correlation between angiographic and hemodynamic findings. This is one of the critical issues we addressed in our Roundtable Discussion as we touched on a broad range of topics related to thromboendarterectomy to bring you the latest thinking from preeminent experts in the United States and abroad.

As we consulted these experts, we turned to the University of California, San Diego, because this center is so widely recog-nized as the world’s leading referral center for pulmonary thromboendarterectomy surgery. Beginning with the pioneering work of Ken Moser, MD, UCSD has contributed enormously to developing guidelines for the evaluation of patients to determine their surgical candidacy and for performance of the procedure itself. Continuing the theme of this issue, two articles written by UCSD investigators provide an in-depth analysis of preoperative and operative considerations. The first begins with the subtle and nonspecific symptoms that may provide the first clues of CTEPH and offers important insights on confirmatory catheterization studies. The second article is an insider’s view of thromboendarterectomy, information that anyone would want to retain as an essential reference for one’s files. The wealth of information presented here highlights how far we have come in the evolution of our thinking about throm-boembolic disease in the setting of PAH. We have made dra-matic strides, moving away from the earlier and simplistic view of its being merely a mechanical obstruction of the major pulmonary arteries. The experience at major centers has redefined our approach and given us important new tools with which to achieve that rare cure in many patients with this disease.

Vic Tapson, MD
Editor-in-Chief

 

Take it With You
 

Download this issue in PDF

Get the Acrobat Reader

 

Issue Sponsor Ads
 

Actelion(PDF)

Accredo Therapeutics(PDF)

 

 

Articles
 
Advances in Pulmonary Hypertension, Spring 2003, Vol. 2, No. 1

Click titles to read stories...

Profiles in Pulmonary Hypertension:
The Legacy of Ken Moser Lives on at UCSD
Behind every great medical program is an invisible presence, a pioneering spirit who established its course and mapped a road to excellence now well traveled by colleagues and new train-ees. The physicians in the Division of Pulmonary and Critical Care Medicine...

Chronic Thromboembolic Pulmonary Hypertension: When to Suspect It, When to Refer for Surgery
Chronic thromboembolic obstruction of the major pulmonary arteries is an underrecognized sequela of acute pulmonary embolism. Depending on the burden and location of thrombus, as well as on the duration of vessel obstruction, chronic thromboembolic disease may lead to pulmonary hypertension and cor pulmonale.

An Insider’s Guide to Pulmonary Thromboendarterectomy: Proven Techniques to Achieve Optimal Results
Pulmonary thromboendarterectomy is the definitive treatment for chronic pulmonary hypertension as the result of thromboembolic disease. Although pulmonary embolism (PE) is one of the more common cardiovascular diseases affecting Americans, pulmonary thromboendarterectomy remains an uncommon procedure, mainly because this form of chronic pul-monary hypertension remains an underdiagnosed condition.

Pulmonary Hypertension Roundtable
Surgically Curable Pulmonary Hypertension: A View From the Experts

Featuring:

Victor F. Tapson, MD
William Auger, MD
Peter Fedullo, MD
Eckhard Mayer, MD
Christopher McGregor, MD

Clinical Algorithm

Evaluation of Chronic Thromboembolic Pulmonary Hypertension (PDF)

 

PHA Announcements
 

Mentored Clinical Scientist Development Award (K08) (PDF)

 

   
Notes
 

Editorial Advisory Board

Editor-in-Chief
Richard Channick, MD
Professor of Clinical Medicine
Pulmonary and Critical Care Division
University of California, San Diego Medical Center
San Diego, California

Immediate Past Editor
Ronald J. Oudiz, MD
Associate Professor of Medicine
The David Geffen School of Medicine at UCLA
Director, Liu Center for Pulmonary Hypertension
LA Biomedical Research Institute at Harbor-UCLA Medical Center

Editor-in-Chief Elect
Erika Berman Rosenzweig, MD
Director, Pulmonary Hypertension Center, Columbia University Medical Center Associate Professor of Clinical Pediatrics (in Medicine)

Associate Editors

Kristin Highland, MD
Assistant Professor of Medicine
Division of Pulmonary, Critical Care, Allergy and Sleep Medicine
Medical University Of Carolina

Francisco Soto, MD, MS
Director, Pulmonary Hypertension Program
Pulmonary and Critical Care Medicine
Medical College of Wisconsin

Todd Bull, MD
Associate Professor of Medicine
Division of Pulmonary Sciences and Critical Care Medicine
University of Colorado Health Sciences Center

Robert Schilz, DO, PhD
Medical Director of Lung
Transplantation and Pulmonary Vascular Disease
University Hospital of Cleveland
Case Western Reserve University
Cleveland, Ohio


Publisher
Pulmonary Hypertension Association
Carl Hicks, Board Chair
Rino Aldrighetti, President
Sherrie Borden, Vice President, Medical and Patient Education

Publishing Staff
Managing Editor
Deborah L. McBride
McBride Strategic Services
mcbridedeb@aol.com
P: 773-348-5455
C: 312-307-5455
Design Director
Michael McClain

PHA Office
Pulmonary Hypertension Association
801 Roeder Road, Ste. 400
Silver Spring, MD 20910
301-565-3004, 301-565-3994 (fax)
www.PHAssociation.org

© 2009 by Pulmonary Hypertension Association. All rights reserved. None of the contents may be reproduced in any form whatsoever without the written permission of PHA.

Advances in Pulmonary Hypertension is circulated to cardiologists, pulmonologists, rheumatologists and other selected physicians by the Pulmonary Hypertension Association. The contents of the articles are independently determined by the Editor and the Editorial Advisory Board.

PHA's Scientific Leadership Council

Editorial Mission
Advances in Pulmonary Hypertension is committed to help physicians in their clinical decision making by informing them of important trends affecting their practice. Analyzing the impact of new findings and covering current information in the peer-reviewed literature, Advances in Pulmonary Hypertension is published four times a year. Advances in Pulmonary Hypertension is the official journal of the Pulmonary Hypertension Association.

Each article in this journal has been reviewed and approved by members of the Editorial Advisory Board.
 

Editorial Board

Charles Burger, MD
Medical Director, PH Clinic
Mayo Clinic
Jacksonville, FL

Karen Fagan, M.D.
Chief, Division of Pulmonary and Critical Care Medicine University of South Alabama

Eli Gabbay, MD
Lung Transplant Unit
Royal Perth Hospital

Nick Kim, M.D.
Associate Clinical Professor of Medicine
University of California San Diego

Deborah Jo Levine, M.D.
University of Texas Health Science Center at San Antonio
San Antonio, TX

Omar Minai, MD
Dept of Pulmonary, Allergy  and Critical Care Medicine

Myung Park, MD
Associate Professor of Medicine
Division of Pulmonary Sciences and Critical Care Medicine
University of Colorado Health Sciences Center

Fernando Torres, MD
Director Pulmonary Hypertension Clinic
UTSW Medical Center Dallas
University Hospital

Glenna Traiger, RN, MSN
Pulmonary & Critical Care
Pulmonary Hypertension CNS
University of California Los Angeles
Los Angeles, CA

R. James White, MD, PhD
Assistant Professor of Medicine, Pharmacology & Physiology
University of Rochester, Division of Pulmonary and CCM

Roham Zamanian, MD
Division of Pulmonary and Critical Care Medicine
Stanford University Medical Center

 

Better Business Bureau Accredited Charity bbb.org/charity Charity Navigator 4 Star Charity Rating best in america seal


The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

Questions about the site? email pha@PHAssociation.org

Pulmonary Hypertension Association
801 Roeder Road, Ste. 400
Silver Spring, MD 20910

Copyright © 2009 Pulmonary Hypertension Association
Read our privacy policy.

For optimal viewing of PHAssociation.org we recommend the following:

PC : Windows running Internet Explorer 5.5 or higher
Macintosh: Internet Explorer 5.2 or higher
free download from Microsoft.com

  Adobe Flash Player
free download from Adobe.com
  Adobe Acrobat Reader 6.0 or higher
free download from Adobe.com
Patients Medical Caregivers Media What is PH